As always if you have any questions reach out to us anytime at email@example.com.
Ichilov Hospital and VAXIL BIO, a company specializing in the development of innovative cancer treatment technologies and infectious diseases, have signed a collaboration to develop a potential peptide vaccine for the Corona COVID-19 virus.
Ichilov Hospital will begin trials for developing a potential vaccine for the coronavirus in collaboration with Israel’s advanced technology company VAXIL.
Vaxil Bio Ltd is a Canadian publicly
listed biotech company (TSX.V:
VXL.V; OTC: VXLLF), based in
Israel that develops innovative patented
technologies in the fields of cancer and
Our focus is on a novel drug discovery
and development platform based on Signal
Peptides which the company deploys to fight
infectious diseases and cancer.